Tommy. On what basis do you pose that question? I see no case for dilution as the company is positioned. Miki
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025